Financial Year |
March 31 2023 |
Monetary Funds |
495,828,222.43 |
Held-for-trading Financial Assets |
331,297,107.85 |
Notes Receivable |
228,000.00 |
Accounts Receivable |
322,015,624.98 |
Advances to Suppliers |
18,305,467.23 |
Other Receivables |
9,314,279.36 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
13,088,263.35 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
4,039,863.14 |
Total Current Assets |
1,194,707,669.10 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
10,486,843.70 |
Investment Properties |
-- |
Fixed Assetes |
276,508,236.20 |
Under-construction Projects |
55,432,642.19 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
82,536,991.00 |
R&D expenses |
-- |
Goodwill |
10,929,080.09 |
Long-Term Deferred and Prepaid Expenses |
67,616,919.70 |
Deferred Income Tax Assets |
14,420,568.90 |
Other Non-Current Assets |
53,987,178.40 |
Sub-Total of Non-Current Assets |
573,336,181.48 |
Total Assets |
1,768,043,850.58 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
120,016,304.91 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
17,045,650.38 |
Taxes Payable |
24,995,064.76 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
27,482,746.48 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
6,277,590.33 |
Other Current Liabilities |
620,509.63 |
Sub-Total of Current Liabilities |
216,258,936.94 |
Long-term Loans |
1,850,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
17,871,217.52 |
Deferred Income Tax Liabilities |
26,146,297.38 |
Other Non-Current Liabilities |
33,860,767.01 |
Sub-Total of Non-Current Liabilities |
108,763,278.94 |
Total Liabilities |
325,022,215.88 |
Paid-In Capital(Or Share Stock) |
90,748,077.00 |
Capital Surplus |
644,371,689.64 |
Surplus Reserve |
45,374,038.50 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
600,782,534.03 |
Minority Stockholder's Interest |
61,745,295.53 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,381,276,339.17 |
Owner's Equity(Stockholder's Equity) |
1,443,021,634.70 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,768,043,850.58 |